Dr Dawit Zemedikun BSc (Econ), MSc (Biostat), PhD, GradStat

Dr Dawit Zemedikun

Department of Applied Health Sciences
Honorary Research Fellow

Contact details

Address
Centre for Health Data Science

Dawit is a Research Fellow in the Cardiovascular Epidemiology Research Centre (CERC) at The University of Western Australia and an Honorary Research Fellow with the Centre for Health Data Science at University of Birmingham.

ORCiD ID: 0000-0003-3642-0456

Google Scholar Profile

ResearchGate profile

ResearcherID profile 

Academia.edu profile 

Qualifications

  • PhD in Health Services Research (Focus on Primary Care & Health Econometrics), University of Birmingham, 2020
  • MSc in Medical Statistics, University of Leicester, 2016
  • Graduate Certificate in Statistics, University of Sheffield, 2015
  • BSc in Economics and Logistics, Molde University-College, Norway, 2001
  • Fellow of the Royal Statistical Society, 2017

Biography

Dawit is an internationally experienced data scientist, epidemiologist, and public health specialist in big real-world data (RWD). He is a medical statistician and a health econometrician by training with professional accreditation (GradStat) from the Royal Statistical Society. Dawit commenced his research career at University of Birmingham (UK) while completing his PhD (2016-2019). Prior to that, his broad skill base was applied in his early professional career across a wide range of areas in the governmental and non-governmental (NGOs) sectors in the UK.

With background in both statistics and economics, Dawit’s research encompasses the intersection of biostatistics, epidemiology, and econometrics. He is interested in using real-world-data/electronic health records (EHRs) to investigate risk factors, trends, early diagnosis/prediction, and economic burden of chronic diseases as well as multimorbidity patterns to better understand disease clusters, their trajectories and underlying mechanisms. 

Publications

Youens, D., Katzenellenbogen, J., Srinivasa, R. R., Sodhi-Berry, N., Carson, J., Zemedikun, D., Thrift, AG., Feigin, V. & Nedkoff, L. Differing definitions of first-ever stroke influence incidence estimates more than trends: a study using linked administrative data. 26 Sept 2023, (In press) In: Neuroepidemiology.

Wells I, Zemedikun DT, Simons G, Stack RJ, Mallen CD, Raza K, Falahee M. Predictors of the likelihood that patients with rheumatoid arthritis will communicate information about rheumatoid arthritis risk to relatives: A quantitative assessment. Patient Educ Couns. 2023 Jul;112:107713. doi: 10.1016/j.pec.2023.107713. 

Gooden TE, Wang J, Zemedikun DT, Taylor S, Greenfield S, Manaseki-Holland S, Nirantharakumar K, Thomas GN. A matched cohort study investigating premature, accentuated, and accelerated aging in people living with HIV. HIV Med. 2023 May;24(5):640-647. doi: 10.1111/hiv.13375. 

Bunnewell S, Wells I, Zemedikun D, Simons G, Mallen CD, Raza K, Falahee M. Predictors of perceived risk in first-degree relatives of patients with rheumatoid arthritis. RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002606. 

Zemedikun DT, Lee H, Nirantharakumar K, Raza K, Chandan JS, Lord JM, Jackson TA. Comorbidity phenotypes and risk of mortality in patients with osteoarthritis in the UK: a latent class analysis. Arthritis Res Ther. 2022 Oct 13;24(1):231. doi: 10.1186/s13075-022-02909-4. 

Sharma-Oates A, Zemedikun DT, Kumar K, Reynolds JA, Jain A, Raza K, Williams JA, Bravo L, Cardoso VR, Gkoutos G, Nirantharakumar K, Lord JM. Early onset of immune-mediated diseases in minority ethnic groups in the UK. BMC Med. 2022 Oct 13;20(1):346. doi: 10.1186/s12916-022-02544-5. 

Umar N, King D, Chandan JS, Bhala N, Nirantharakumar K, Adderley N, Zemedikun DT, Harvey P, Trudgill N. The association between inflammatory bowel disease and mental ill health: a retrospective cohort study using data from UK primary care. Aliment Pharmacol Ther. 2022 Sep;56(5):814-822. doi: 10.1111/apt.17110. 

Subramanian A, Han D, Braithwaite T, Thayakaran R, Zemedikun DT, Gokhale KM, Lee WH, Coker J, Keane PA, Denniston AK, Nirantharakumar K, Azoulay L, Adderley NJ. Angiotensin-converting enzyme inhibitors and risk of age-related macular degeneration in individuals with hypertension. Br J Clin Pharmacol. 2022 Sep;88(9):4199-4210. doi: 10.1111/bcp.15366. 

Thayakaran R, Goel R, Adderley NJ, Chandan JS, Zemedikun D, Nirantharakumar K, Harper L. Cluster analysis of patients with granulomatosis with polyangiitis (GPA) based on clinical presentation symptoms: a UK population-based cohort study. Arthritis Res Ther. 2022 Aug 19;24(1):201. doi: 10.1186/s13075-022-02885-9. 

Wells I, Zemedikun DT, Simons G, Stack RJ, Mallen CD, Raza K, Falahee M. Predictors of interest in predictive testing for rheumatoid arthritis among first degree relatives of rheumatoid arthritis patients. Rheumatology (Oxford). 2022 Aug 3;61(8):3223-3233. doi: 10.1093/rheumatology/keab890. 

Haroon S, Nirantharakumar K, Hughes SE, Subramanian A, Aiyegbusi OL, Davies EH, Myles P, Williams T, Turner G, Chandan JS, McMullan C, Lord J, Wraith DC, McGee K, Denniston AK, Taverner T, Jackson LJ, Sapey E, Gkoutos G, Gokhale K, Leggett E, Iles C, Frost C, McNamara G, Bamford A, Marshall T, Zemedikun DT, Price G, Marwaha S, Simms-Williams N, Brown K, Walker A, Jones K, Matthews K, Camaradou J, Saint-Cricq M, Kumar S, Alder Y, Stanton DE, Agyen L, Baber M, Blaize H, Calvert M. Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study). BMJ Open. 2022 Apr 26;12(4):e060413. doi: 10.1136/bmjopen-2021-060413. 

Zemedikun DT, Chandan JS, Raindi D, Rajgor AD, Gokhale KM, Thomas T, Falahee M, De Pablo P, Lord JM, Raza K, Nirantharakumar K. Burden of chronic diseases associated with periodontal diseases: a retrospective cohort study using UK primary care data. BMJ Open. 2021 Dec 19;11(12):e048296. doi: 10.1136/bmjopen-2020-048296. 

Zemedikun DT, Gokhale K, Chandan JS, Cooper J, Lord JM, Filer A, Falahee M, Nirantharakumar K, Raza K. Type 2 diabetes mellitus, glycaemic control, associated therapies and risk of rheumatoid arthritis: a retrospective cohort study. Rheumatology (Oxford). 2021 Dec 1;60(12):5567-5575. doi: 10.1093/rheumatology/keab148. 

Okoth K, Wang J, Zemedikun D, Thomas GN, Nirantharakumar K, Adderley NJ. Risk of cardiovascular outcomes among women with endometriosis in the United Kingdom: a retrospective matched cohort study. BJOG. 2021 Sep;128(10):1598-1609. doi: 10.1111/1471-0528.16692. 

Zemedikun DT, Kigozi J, Wynne-Jones G, Guariglia A, Roberts T. Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review. PLoS One. 2021;16(5):e0251406. doi: 10.1371/journal.pone.0251406.

Chandan JS, Zemedikun DT, Thayakaran R, Byne N, Dhalla S, Acosta-Mena D, Gokhale KM, Thomas T, Sainsbury C, Subramanian A, Cooper J, Anand A, Okoth KO, Wang J, Adderley NJ, Taverner T, Denniston AK, Lord J, Thomas GN, Buckley CD, Raza K, Bhala N, Nirantharakumar K, Haroon S. Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19. Arthritis Rheumatol. 2021 May;73(5):731-739. doi: 10.1002/art.41593. 

Wang J, Cooper JM, Gokhale K, Acosta-Mena D, Dhalla S, Byne N, Chandan JS, Anand A, Okoth K, Subramanian A, Bangash MN, Jackson T, Zemedikun D, Taverner T, Hanif W, Ghosh S, Narendran P, Toulis KA, Tahrani AA, Surenthirakumaran R, Adderley NJ, Haroon S, Khunti K, Sainsbury C, Thomas GN, Nirantharakumar K. Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes. J Clin Endocrinol Metab. 2021 Apr 23;106(5):1255-1268. doi: 10.1210/clinem/dgab067.

Haroon S, Subramanian A, Cooper J, Anand A, Gokhale K, Byne N, Dhalla S, Acosta-Mena D, Taverner T, Okoth K, Wang J, Chandan JS, Sainsbury C, Zemedikun DT, Thomas GN, Parekh D, Marshall T, Sapey E, Adderley NJ, Nirantharakumar K. Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care. BMC Infect Dis. 2021 Mar 15;21(1):262. doi: 10.1186/s12879-021-05951-w. 

Chandan JS, Keerthy D, Zemedikun DT, Okoth K, Gokhale KM, Raza K, Bandyopadhyay S, Taylor J, Nirantharakumar K. The association between exposure to childhood maltreatment and the subsequent development of functional somatic and visceral pain syndromes. EClinicalMedicine. 2020 Jun;23:100392. doi: 10.1016/j.eclinm.2020.100392. 

Crowe F, Zemedikun DT, Okoth K, Adderley NJ, Rudge G, Sheldon M, Nirantharakumar K, Marshall T. Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK. Heart. 2020 Jun;106(11):810-816. doi: 10.1136/heartjnl-2019-316091. 

Krishna MT, Subramanian A, Adderley NJ, Zemedikun DT, Gkoutos GV, Nirantharakumar K. Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis. Eur Respir J. 2019 Nov;54(5). doi: 10.1183/13993003.00476-2019. 

Zemedikun DT, Gray LJ, Khunti K, Davies MJ, Dhalwani NN. Patterns of Multimorbidity in Middle-Aged and Older Adults: An Analysis of the UK Biobank Data. Mayo Clin Proc. 2018 Jul;93(7):857-866. doi: 10.1016/j.mayocp.2018.02.012.